BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5433161)

  • 1. Human fertility control by transvaginal application of quinacrine on the fallopian tube.
    Zipper JA; Stachetti E; Medel M
    Fertil Steril; 1970 Aug; 21(8):581-9. PubMed ID: 5433161
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinico-pathological study of fallopian tubes after transcervical insertion of quinacrine hydrochloride pellets.
    Merchant RN; Doctor VM; Thaku SS; Sinha M; Jhaveri CL; Kessel E; Mumford SD
    Adv Contracept; 1986 Mar; 2(1):79-90. PubMed ID: 3776739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsurgical female sterilization.
    Laufe LE; Cole LP
    Int J Gynaecol Obstet; 1980; 18(5):334-9. PubMed ID: 6110577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinacrine-induced pathologic changes in the fallopian tube.
    Bhatt RV; Aparicio A; Laufe LE; Parmley T; King TM
    Fertil Steril; 1980 Jun; 33(6):666-7. PubMed ID: 7380052
    [No Abstract]   [Full Text] [Related]  

  • 5. Quinacrine-induced occlusive fibrosis in the human fallopian tube is due to a unique inflammatory response and modification of repair mechanisms.
    Growe RG; Luster MI; Fail PA; Lippes J
    J Reprod Immunol; 2013 Apr; 97(2):159-66. PubMed ID: 23453701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year follow-up of insertion of quinacrine hydrochloride pellets as a means of nonsurgical female sterilization.
    Bhatt R; Waszak CS
    Fertil Steril; 1985 Sep; 44(3):303-6. PubMed ID: 4029417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinacrine hydrochloride. Review and mode of action of an antimalarial, used as an occlusive agent for transvaginal human sterilization.
    Patek E
    Acta Obstet Gynecol Scand; 1979; 58(6):561-4. PubMed ID: 550697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential single insertion protocol for quinacrine pellet non-surgical female sterilization.
    Mullick BC; Kessel E; Mumford SD
    Adv Contracept; 1995 Sep; 11(3):239-44. PubMed ID: 8533626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-year clinical evaluation of quinacrine pellets for non-surgical female sterilization.
    Suhadi A; Anwar M; Soejoenoes A
    Adv Contracept; 1998 Mar; 14(1):69-77. PubMed ID: 9587010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical occlusion of Rhesus Monkey oviducts with quinacrine.
    Chandra H; Malaviya B; Kar AB
    Indian J Exp Biol; 1974 Sep; 12(5):447-8. PubMed ID: 4448496
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinacrine sterilization (QS): time for reconsideration.
    Lippes J
    Contraception; 2015 Aug; 92(2):91-5. PubMed ID: 26072742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transvaginal chemical sterilization: clinical use of quinacrine plus potentiating adjuvants.
    Zipper J; Stacchetti E; Medel M
    Contraception; 1975 Jul; 12(1):11-21. PubMed ID: 1139945
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of repeated transcervical quinacrine pellet insertions for female sterilization.
    el Kady AA; Nagib HS; Kessel E
    Fertil Steril; 1993 Feb; 59(2):301-4. PubMed ID: 8425622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female sterilization with quinacrine using hysterosalpingography (HSG) as an endpoint after a single-insertion protocol in Caracas, Venezuela.
    Giugni Chalbaud A; Plaza Mora G
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 2():S107-11. PubMed ID: 14763195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of quinacrine sterilization (QS) and surgical sterilization (TL) in 600 women in Guizhou Province, China.
    Lu W; Zhu J; Zhong C; Zhao Y
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 2():S51-8. PubMed ID: 14763186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female sterilization in current clinical practice.
    Porter CW; Hulka JF
    Fam Plann Perspect; 1974; 6(1):30-8. PubMed ID: 4282075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinacrine sterilization (QS) in Iran and the use of HSG as a measure of success.
    Soroodi-Moghaddam S
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 2():S93-6. PubMed ID: 14763192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinacrine sterilization (QS) in Costa Rica: 694 cases.
    Alpizar F
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 2():S141-5. PubMed ID: 14763203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25 years of quinacrine sterilization experience in Chile: review of 2,592 cases.
    Zipper J; Trujillo V
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 2():S23-9. PubMed ID: 14763182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An FDA phase I clinical trial of quinacrine sterilization (QS).
    Lippes J; Brar M; Gerbracht K; Neff P; Kokkinakis S
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 2():S45-9. PubMed ID: 14763185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.